Resistance to therapy caused by intragenic deletion in BRCA2
Breast Cancer Now · Institute of Cancer Research · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,000
total citations
- FWCI
- 33.13
- Percentile
- 100%
- References
- 31
Citations per year
Authors
9- SLStacey L. EdwardsCorresponding
Breast Cancer Now, Institute of Cancer Research
- RBRachel Brough
Breast Cancer Now, Institute of Cancer Research
- CJChristopher J. Lord
Breast Cancer Now, Institute of Cancer Research
- RNRachael Natrajan
Breast Cancer Now, Institute of Cancer Research
- RVRadost Vatcheva
Breast Cancer Now, Institute of Cancer Research
Topics & keywords
Topics
Keywords
- Frameshift mutation
- Biology
- Mutation
- BRCA2 Protein
- RAD51
- Molecular biology
- Genetics
- PARP inhibitor
No related works found for this paper.